Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Novel Triple-dose Tuberculosis Retreatment Regimen: How to Overcome Resistance Without Creating More in Niger

NCT04260477 is registered in ClinicalTrials.gov with Institute of Tropical Medicine, Belgium as lead sponsor.

NCT NCT04260477
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04260477 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Novel Triple-dose Tuberculosis Retreatment Regimen: How to Overcome Resistance Without Creating More in Niger
Lead sponsor
Institute of Tropical Medicine, Belgium
Phase
Phase 3
Overall status
Recruiting
Start date
March 1, 2021
Completion date
September 30, 2025
Enrollment
370 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

multidrug-resistant tuberculosis, pulmonary tuberculosis, resistance to tuberculostatic drugs, tuberculosis